CBDNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Out-licenses Disruptive Delivery Technology to Strategically Build Cash Flow
Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) has been strategically out-licensing its disruptive delivery technology and focusing on R&D to improve its value and increase cash flow. An article further discussing the company reads: “Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) CEO Chris Bunka said in a recent CFN Media Group interview that his company has gained in value and cash flow, purposely keeping its cash burn rate down and evaluating technology applications for both cannabis and other sectors (http://cnw.fm/4MDyw). … Bunka explained that LXRP is respecting its shareholders in terms of lowered spending and increasing its valuation, purposely maintaining its…






